DNA Methylation Patterns of a Satellite Non-coding Sequence - FA-SAT in Cancer Cells: Its Expression Cannot Be...

Area of Science:

• Genomics
• Epigenetics
• Cancer Biology

Background:

• Satellite non-coding RNAs (ncRNAs) are increasingly recognized for their roles in cellular and cancer pathways.
• Hypomethylation of cancer-associated satellite DNA is often linked to the overexpression of satellite non-coding DNAs in tumors.
• FA-SAT, the primary satellite DNA in domestic cats (Felis catus), possesses GC-rich regions and a CpG island, suggesting potential regulation by DNA methylation.

Purpose of the Study:

• To investigate the DNA methylation profile of FA-SAT in feline primary cells, a feline tumor cell line (FkMTp), and feline mammary tumors.
• To determine the correlation between FA-SAT methylation status and its transcription levels in healthy and cancerous feline tissues.
• To explore the impact of global DNA demethylation on FA-SAT expression using 5-Azacytidine.

Main Methods:

• Analysis of FA-SAT DNA methylation patterns in cat primary cells, FkMTp cell line passages, and feline mammary tumors versus matched disease-free tissues.
• Quantification of FA-SAT non-coding RNA transcription levels.
• Treatment of feline primary cells and FkMTp cells with the demethylating agent 5-Azacytidine to assess its effect on FA-SAT expression.

Main Results:

• Contrary to expectations, FA-SAT DNA was not hypomethylated in most analyzed tumor samples.
• FA-SAT transcription levels did not consistently correlate with its methylation status in tumor samples.
• Global demethylation with 5-Azacytidine increased FA-SAT non-coding RNA in primary cells but only the small RNA fraction in FkMTp tumor cells.

Conclusions:

• DNA methylation of FA-SAT plays a role in regulating this satellite DNA sequence.
• Additional regulatory mechanisms, beyond DNA methylation, are involved in controlling FA-SAT transcription, particularly in the context of feline cancer.
• The findings challenge the generalized model of satellite DNA hypomethylation in cancer for FA-SAT.